Select M&As in U.S. and Europe biotechnology industry 2016

Selected biotechnology mergers and acquisitions in the U.S. and Europe by total potential value in 2016 (in million U.S. dollars)

by Matej Mikulic, last edited Dec 4, 2018
Select M&As in U.S. and Europe biotechnology industry 2016 This statistic shows the total potential value of select mergers and acquisitions in the United States and the European biotechnology industry in 2016. During this year, Irish company Shire acquired U.S. company Baxalta with a potential value of 32 billion U.S. dollars.
Show more

Selected biotechnology mergers and acquisitions in the U.S. and Europe by total potential value in 2016 (in million U.S. dollars)

Loading statistic...
Expand statistic
Acquirer (Target)Total potential value in million U.S. dollars
Shire (Baxalta)32,000
Pfizer (Medivation)14,000
Mylan (Meda)9,900
AbbVie (Stemcentrx)9,800
Pfizer (Anacor)5,200
Danaher (Cepheid)4,000
Celgene (EngMab)3,080
Celgene (Acetylon)2,446
Allergan (Tobira Therapeutics)1,695
Galenica (Relypsa)1,530
Jazz Pharmaceuticals (Celator)1,500
Astellas Pharma (Ganymed)1,418
Thermo Fisher Scientific (Affymetrix)1,300
Merck & Co. (Afferent)1,250
Gilead Sciences (Nimbus Apollo)1,200
Allergan (Chase)1,000
Acquirer (Target)Total potential value in million U.S. dollars
Shire (Baxalta)32,000
Pfizer (Medivation)14,000
Mylan (Meda)9,900
AbbVie (Stemcentrx)9,800
Pfizer (Anacor)5,200
Danaher (Cepheid)4,000
Celgene (EngMab)3,080
Celgene (Acetylon)2,446
Allergan (Tobira Therapeutics)1,695
Galenica (Relypsa)1,530
Jazz Pharmaceuticals (Celator)1,500
Astellas Pharma (Ganymed)1,418
Thermo Fisher Scientific (Affymetrix)1,300
Merck & Co. (Afferent)1,250
Gilead Sciences (Nimbus Apollo)1,200
Allergan (Chase)1,000
Download Settings Share
Download started
Please be patient - this may take a moment
by Matej Mikulic, last edited Dec 4, 2018
This statistic shows the total potential value of select mergers and acquisitions in the United States and the European biotechnology industry in 2016. During this year, Irish company Shire acquired U.S. company Baxalta with a potential value of 32 billion U.S. dollars.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Biotechnology in Germany"
  • Overview
The most important statistics
  • Biopharmaceutical market
  • Research and components
  • Funding
  • Occupation
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.